The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid
Eagle, H., Oyama, V. I., Levy, M., Horton, C. L., & Fleischman, R. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65826-0 · Cited by 354
Hendershot, L., Bole, D., Köhler, G., & Kearney, J. F. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.3.761 · Cited by 340
Cited by
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Advances in Mammalian cell line development technologies for recombinant protein production
Lai, T., Yang, Y., & Ng, S. (2013) · Pharmaceuticals · doi:10.3390/ph6050579 · Cited by 322
Guidelines to cell engineering for monoclonal antibody production
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178
Advances in animal cell recombinant protein production: GS-NS0 expression system
Barnes, L. M., Bentley, C. M., & Dickson, A. J. (2000) · Cytotechnology · doi:10.1023/a:1008170710003 · Cited by 129
Generation of Mammalian Cells Stably Expressing Multiple Genes at Predetermined Levels
Liu, X., Constantinescu, S. N., Sun, Y., Bogan, J. S., Hirsch, D., Weinberg, R. A., & Lodish, H. F. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4478 · Cited by 128
Smales, C. M., Dinnis, D. M., Stansfield, S. H., Alete, D., Sage, E. A., Birch, J. R., Racher, A. J., Marshall, C. T., & James, D. C. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20272 · Cited by 119
Metabolic responses of CHO cells to limitation of key amino acids
Duarte, T. M., Carinhas, N., Barreiro, L. C., Carrondo, M. J. T., Alves, P. M., & Teixeira, A. P. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25266 · Cited by 110
Construction of engineered CHO strains for high-level production of recombinant proteins
M., K., S., I., Y., F., K., Y., & T., S. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1134-1 · Cited by 95
Xu, P., Clark, C., Ryder, T., Sparks, C., Zhou, J., Wang, M., Russell, R., & Scott, C. (2017) · Biotechnology Progress · doi:10.1002/btpr.2417 · Cited by 83
An efficient and targeted gene integration system for high-level antibody expression
Huang, Y., Li, Y., Wang, Y. G., Gu, X., Wang, Y., & Shen, B. F. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.01.022 · Cited by 75
Ghorbaniaghdam, A., Chen, J., Henry, O., & Jolicoeur, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090832 · Cited by 71
Schiedner, G., Hertel, S., Bialek, C., Kewes, H., Waschütza, G., & Volpers, C. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-13 · Cited by 50
Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells
Khoo, S. H. G., & Al‐Rubeai, M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22041 · Cited by 38
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
Evaluation of the OSCAR™ system for the production of monoclonal antibodies by CHO-K1 cells
Costa, A. R., Rodrigues, M. E., Henriques, M., Melton, D., Cunnah, P., Oliveira, R., & Azeredo, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.028 · Cited by 12
Metadata
- Authors
- Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., & Yarranton, G. T.
- Venue
- Nature Biotechnology
- Published
- 1992-02
- Volume
- 10
- Issue
- 2
- Pages
- 169-175
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2000213886
- Cited by
- 462
- References
- 2
- FWCI
- 27.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
